Prescription Drug Pricing
Chief executive officers from seven prescription drug companies testified before the Senate Finance Committee on drug pricing practices.… read more
Chief executive officers from seven prescription drug companies testified before the Senate Finance Committee on drug pricing practices. Members asked the executives how their companies set prices, determine rebates, and why prices for patients vary from country to country. The executives talked about their research and development costs relative to revenues and profits, and each stressed their commitment to providing all patients the medicines they need regardless of listed prices. Senator Bob Menendez (D-NJ) warned them, however, that there was bipartisan support to ensure drug prices were brought down, and said that if the companies did not address the issue themselves, Congress or President Trump would take action to force them to do so. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
More PeopleHosting Organization
Featured Clips from This Video
-
Senator Menendez Warns Drug Company CEOs to Lower Prices
New Jersey Democratic Senator Bob Menendez issues a "friendly warning" to the CEO's of several pharmaceutical companies…
- 1 minute
- 520 views
Related Video
-
Emmarie Huetteman on the Cost of Prescription Drugs
Emmarie Huetteman talked about the Senate Finance Committee hearing on drug prices, which included representatives from…
-
Open Phones, Part 1
Telephone lines and social media were open to take viewer calls and comments to the question, “Should there be a federal role…
-
Consumer Financial Protection Bureau Oversight
Consumer Financial Protection Bureau Director Kathleen Kraninger testified on the agency’s semi-annual report to…
-
Data Privacy and Protection
Technology experts and privacy advocates testified before the Senate Commerce Committee on consumer data privacy. The…